| |
| |
|
| Insider
Information: |
Homcy Charles J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,546,413 |
|
|
Indirect Shares
|
188,122 |
|
|
| Direct
Value |
$42,372,241 |
|
|
|
Indirect Value
|
$3,452,400 |
|
|
| Total
Shares |
1,734,535 |
|
|
| Total
Value |
$45,824,641 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
Director |
2008-05-09 |
0 |
2004-02-17 |
1,119 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2011-05-11 |
62,751 |
2007-01-03 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2019-01-02 |
112,471 |
2019-01-02 |
185,403 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2017-10-27 |
67,728 |
2017-10-27 |
1,600 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-02-16 |
1,230,085 |
2019-07-01 |
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
73,378 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,228,297 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-11-16 |
4 |
D |
$28.86 |
$37,547 |
D/D |
(1,301) |
1,226,996 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-02-16 |
4 |
D |
$37.21 |
$56,150 |
D/D |
(1,509) |
1,230,085 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,231,594 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2007-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2007-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,146 |
27,146 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2008-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,038 |
37,184 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2009-05-29 |
4 |
A |
$0.00 |
$19,997 |
D/D |
28,067 |
65,251 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2010-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
70,251 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2010-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
115,251 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2011-05-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,500) |
62,751 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
120,251 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,600 |
|
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
212,685 |
|
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2016-11-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2016-11-03 |
5 |
A |
$0.00 |
$0 |
D/D |
14,611 |
227,296 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2016-11-14 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2016-12-16 |
5 |
A |
$0.00 |
$0 |
D/D |
10,432 |
237,728 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-03-02 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-06-01 |
4 |
S |
$26.58 |
$486,345 |
D/D |
(18,299) |
219,429 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-06-02 |
4 |
S |
$26.92 |
$2,222,124 |
D/D |
(81,701) |
137,728 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-10-03 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-10-04 |
4 |
S |
$0.00 |
$0 |
I/I |
(0) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-10-26 |
4 |
S |
$33.93 |
$1,845,781 |
D/D |
(54,400) |
83,328 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2017-10-27 |
4 |
S |
$34.09 |
$531,770 |
D/D |
(15,600) |
67,728 |
0 |
- |
|
108 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
